CyberKnife is the only FDA approved completely Robotic Stereotactic Radiosurgery System available in the world that targets and destroys tumors and lesions anywhere in the body. This non-invasive "surgery" kills the cancer while preserving healthy tissue, because it has unmatched maneuverability in precisely targeting tumors and lesions.
Advantages of CyberKnife
The radiation dose to organs at risk is minimal, even those
that are immediately adjacent to the lesion.
No head or body frame is required because patient movement is
detected and compensated by adaptive beam pointing.
Staged/fractionated radiosurgery for intracranial and head
lesions is now possible with CyberKnife.
Since no head or body frames are required, CyberKnife
treatments can be performed in one to five fractions. This enables the
administration of an effective dose of radiation to a lesion while mitigating
the injurious effects to critical
structures/organs at risk.
CyberKnife has revolutionized the patient's quality of life:
Instead of coming in for treatment every day for six to eight
weeks, CyberKnife patients only have to come in for one to five days. This
shorter treatment course is more convenient and less stressful for patients and
Since neither incisions nor general anesthesia is required in
a CyberKnife procedure, the risk of complications, and therefore recovery time,
is dramatically reduced or totally eliminated after a CyberKnife treatment.
Patients can even return to work on the same day they had a treatment.